Formpipe Preliminary Q4: High Costs Hurting Margins
Research Note
2025-01-20
08:58
Redeye comments on the preliminary Q4 figures from Formpipe. While hurting Q4 2024, the implications for 2025 and onwards are likely minor. However, the important ACV/ARR figures are not yet disclosed.
Fredrik Nilsson
Disclosures and disclaimers